Evidence map›Paper›PMID 24367161›Full record

ReviewBreast cancer (Dove Medical Press)2009

EGFR may couple moderate alcohol consumption to increased breast cancer risk.

Christopher P Mill, Julia A Chester, David J Riese

Open access · goldAbstract readReview
In one paragraph

Review in Breast cancer (Dove Medical Press), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Alcohol and breast cancer.Pharmacological reports : PR · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. The Unique Dopamine/Ecdysteroid Receptor Modulates Ethanol-Induced Sedation in Drosophila.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. EGFR signaling in breast cancer: bad to the bone.Seminars in cell & developmental biology · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Christopher P MillPurdue University School of Pharmacy, Purdue University Center for Cancer Research, West Lafayette, IN, USA.
Julia A ChesterPurdue University Department of Psychological Sciences, West Lafayette, IN, USA.
David J RiesePurdue University School of Pharmacy, Purdue University Center for Cancer Research, West Lafayette, IN, USA.
Purdue University West Lafayette · US

Funding

Regulation of ErbB4 Signaling by Neuregulin IsoformsR01CA114209 · NCI · PURDUE UNIVERSITY · PI RIESE, DAVID J. · 2006 to 2010
$1.2M
NCI NIH HHS R01 CA114209
6 · The paper itself

Abstract

Alcohol consumption is an established risk factor for breast cancer. Nonetheless, the mechanism by which alcohol contributes to breast tumor initiation or progression has yet to be definitively established. Studies using cultured human tumor cell lines have identified signaling molecules that may contribute to the effects of alcohol, including reactive oxygen species and other ethanol metabolites, matrix metalloproteases, the ErbB2/Her2/Neu receptor tyrosine kinase, cytoplasmic protein kinases, adenylate cyclase, E-cadherins, estrogen receptor, and a variety of transcription factors. Emerging data suggest that the epidermal growth factor receptor (EGFR) tyrosine kinase may contribute to breast cancer genesis and progression. Here we integrate these findings and propose three mechanisms by which alcohol contributes to breast cancer. A common feature of these mechanisms is increased EGFR signaling. Finally, we discuss how these mechanisms suggest strategies for addressing the risks associated with alcohol consumption.

Indexed as

alcoholbreast cancer risk factorEGF receptormatrix metalloprotease

Identifiers

PMID24367161
PMCPMC2872252
OpenAlexW2162889729

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.